Plus Therapeutics Presents New Health Economics Study Evaluating Economic Impact Of Earlier Detection And Therapeutic Management Of LM Using CNSide Cerebrospinal Fluid Assay

PLUS THERAPEUTICS INC

PLUS THERAPEUTICS INC

PSTV

0.00

Plus Therapeutics Presents New Health Economics Study Evaluating Economic Impact Of Earlier Detection And Therapeutic Management Of LM Using CNSide Cerebrospinal Fluid Assay